Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Antiviral therapy `economically reasonable' in influenza virus infections

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Antiviral therapy `economically reasonable' in influenza virus infections. Pharmacoecon. Outcomes News 387, 5 (2002). https://doi.org/10.1007/BF03279814

    Download citation

    Keywords

    • Influenza
    • Incremental Cost
    • Antiviral Therapy
    • Oseltamivir
    • Amantadine